Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Walker, J. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Commentary: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?

James D Walker

Medical Unit, St Johns Hospital, Livingston, EH54 6PP, UK, james.walker{at}wlt.scot.nhs.uk

The authors in the preceding paper have answered a number of specific questions regarding the management of diabetic renal disease. Using a systematic review, they have concluded that although urinary albumin excretion decreases in patients randomised to lower blood pressure (BP) levels within the normotensive range (< 140/90 mmHg), no trials to-date have demonstrated a beneficial effect on glomerular filtration rate (GFR). Thus, the authors state that the available literature does not provide dat S a to support the assertion that BP-lowering within the normotensive range reduces the risk of renal replacement therapy. However, these findings require interpretation before they can influence clinical practice. The benefits of BP-lowering extend far beyond the glomerulus — a fact of crucial importance in terms of the macrovasculopathy so frequently seen inpatients with diabetic renal disease. Moreover, achieving BP levels within the normotensive range in these patients is in itself a success. The analysis provided by Kaiser et al. does suggest that, rather than lowering BP within the normotensive range, other therapeutic avenues may be more fruitfully explored to maximise health gain in this high-risk cohort.

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 4, 282-284 (2003)
DOI: 10.1177/14746514030030040901
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?